News Release Details
Entegris Reports Results for Fourth Quarter Of 2022
-
Fourth-quarter revenue (as reported) of
$946 million , increased 49% from prior year - Fourth-quarter revenue (proforma), increased 1%
- Full-year 2022 revenue (as reported), increased 43% from prior year
- Full-year 2022 revenue (proforma), increased 13%
-
Fourth-quarter GAAP diluted EPS of
$0.38 -
Fourth-quarter non-GAAP diluted EPS of
$0.83
Quarterly Financial Results Summary
(in thousands, except percentages and per share data)
GAAP Results |
|
|
|
Net sales |
|
|
|
Operating income |
|
|
|
Operating margin - as a % of net sales |
15.2% |
25.1% |
1.5% |
Net income (loss) |
|
|
|
Diluted earnings (loss) per common share |
|
|
|
Non-GAAP Results |
|||
Non-GAAP adjusted operating income |
|
|
|
Non-GAAP adjusted operating margin - as a % of net sales |
23.2% |
27.8% |
25.5% |
Non-GAAP net income |
|
|
|
Diluted non-GAAP earnings per common share |
|
|
|
First-Quarter Outlook
For the first quarter ending
Segment Results
In connection with the completion of the CMC Materials acquisition, the company now operates in four segments (which include the new APS division):
Specialty Chemicals and Engineered Materials (SCEM): SCEM provides advanced materials enabling complex chip designs and improved device electrical performance; including high-performance and high-purity process chemistries, gases and materials and safe and efficient delivery systems to support semiconductor and other advanced manufacturing processes.
Microcontamination Control (MC): MC offers advanced filtration solutions that improve customers’ yield, device reliability and cost; by filtering and purifying critical liquid chemistries and gases used in semiconductor manufacturing processes and other high-technology industries.
Advanced Materials Handling (AMH): AMH develops solutions that improve customers’ yields by protecting critical materials during manufacturing, transportation, and storage; including products that monitor, protect, transport and deliver critical liquid chemistries, wafers, and other substrates for a broad set of applications in the semiconductor, life sciences and other high-technology industries.
Advanced Planarization Solutions (APS): APS develops an end-to-end chemical mechanical planarization (CMP) solution and applications expertise delivered through advanced materials and high purity chemicals; including CMP slurries, pads, formulated cleans and other electronic chemicals used in the semiconductor manufacturing processes.
Fourth-Quarter Results Conference Call Details
Entegris will hold a conference call to discuss its results for the fourth quarter on
Management’s slide presentation concerning the results for the fourth quarter will be posted on the Investor Relations section of www.entegris.com in the morning before the call.
About Entegris
Entegris is a world-class supplier of advanced materials and process solutions for the semiconductor and other high-tech industries. Entegris has approximately 10,000 employees throughout its global operations and is ISO 9001 certified. It has manufacturing, customer service and/or research facilities in
Non-GAAP Information
The Company’s condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in
Cautionary Note on Forward Looking Statements
This news release contains forward looking statements. The words “believe,” “expect,” “anticipate,” “intend,” “estimate,” “forecast,” “project,” “should,” “may,” “will,” “would” or the negative thereof and similar expressions are intended to identify such forward looking statements. These forward looking statements may include statements about the ongoing impacts of the COVID-19 pandemic and the conflict in
Condensed Consolidated Statements of Operations (In thousands, except per share data) (Unaudited) |
|||
|
Three months ended |
||
|
|
|
|
Net sales |
|
|
|
Cost of sales |
541,545 |
340,114 |
622,157 |
Gross profit |
404,525 |
295,090 |
371,671 |
Selling, general and administrative expenses |
139,246 |
77,366 |
226,446 |
Engineering, research and development expenses |
68,041 |
45,940 |
64,990 |
Amortization of intangible assets |
53,462 |
12,240 |
65,346 |
Operating income |
143,776 |
159,544 |
14,889 |
Interest expense, net |
82,013 |
9,434 |
82,755 |
Other (income) expense, net |
(3,447) |
1,888 |
12,852 |
Income (loss) before income tax expense |
65,210 |
148,222 |
(80,718) |
Income tax expense (benefit) |
7,783 |
30,003 |
(7,015) |
Net income (loss) |
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per common share: |
|
|
|
Diluted earnings (loss) per common share: |
|
|
|
|
|
|
|
Weighted average shares outstanding: |
|
|
|
Basic |
149,039 |
135,495 |
148,570 |
Diluted |
149,909 |
136,629 |
148,570 |
Condensed Consolidated Statements of Operations (In thousands, except per share data) (Unaudited) |
||
|
Twelve months ended |
|
|
|
|
Net sales |
|
|
Cost of sales |
1,885,620 |
1,239,229 |
Gross profit |
1,396,413 |
1,059,664 |
Selling, general and administrative expenses |
543,485 |
292,408 |
Engineering, research and development expenses |
228,994 |
167,632 |
Amortization of intangible assets |
143,953 |
47,856 |
Operating income |
479,981 |
551,768 |
Interest expense, net |
208,975 |
40,997 |
Other expense, net |
23,926 |
31,695 |
Income before income tax expense |
247,080 |
479,076 |
Income tax expense |
38,160 |
69,950 |
Net income |
|
|
|
|
|
|
|
|
Basic earnings per common share: |
|
|
Diluted earnings per common share: |
|
|
|
|
|
Weighted average shares outstanding: |
|
|
Basic |
142,294 |
135,411 |
Diluted |
143,146 |
136,574 |
Condensed Consolidated Balance Sheets (In thousands) (Unaudited) |
||
|
|
|
ASSETS |
|
|
Current assets: |
|
|
Cash, cash equivalents and restricted cash |
|
|
Trade accounts and notes receivable, net |
535,485 |
347,413 |
Inventories, net |
812,815 |
475,213 |
Deferred tax charges and refundable income taxes |
47,618 |
35,312 |
Assets held-for-sale |
246,531 |
— |
Other current assets |
129,297 |
52,867 |
Total current assets |
2,335,185 |
1,313,370 |
Property, plant and equipment, net |
1,393,337 |
654,098 |
Other assets: |
|
|
Right-of-use assets |
94,940 |
66,563 |
|
4,408,331 |
793,702 |
Intangible assets, net |
1,841,955 |
335,113 |
Deferred tax assets and other noncurrent tax assets |
28,867 |
17,671 |
Other |
36,242 |
11,379 |
Total assets |
|
|
LIABILITIES AND EQUITY |
|
|
Current liabilities |
|
|
Short-term debt, including current portion of long-term debt |
|
— |
Accounts payable |
172,488 |
130,734 |
Accrued liabilities |
328,784 |
199,131 |
Liabilities held-for-sale |
10,637 |
— |
Income tax payable |
98,057 |
49,136 |
Total current liabilities |
761,931 |
379,001 |
Long-term debt, excluding current maturities |
5,632,928 |
937,027 |
Long-term lease liability |
80,716 |
60,101 |
Other liabilities |
445,282 |
101,986 |
Shareholders’ equity |
3,218,000 |
1,713,781 |
Total liabilities and equity |
|
|
Condensed Consolidated Statements of Cash Flows (In thousands) (Unaudited) |
||||
|
Three months ended |
Twelve months ended |
||
|
|
|
|
|
Operating activities: |
|
|
|
|
Net income |
|
|
|
|
Adjustments to reconcile net (loss) income to net cash provided by operating activities: |
|
|
|
|
Depreciation |
41,882 |
22,801 |
135,371 |
90,311 |
Amortization |
53,462 |
12,240 |
143,953 |
47,856 |
Share-based compensation expense |
9,033 |
7,760 |
66,577 |
29,884 |
Loss on extinguishment of debt and modification |
1,052 |
— |
3,287 |
23,338 |
Other |
(28,678) |
(1,354) |
32,542 |
(3,330) |
Changes in operating assets and liabilities, net of effects of acquisitions: |
|
|
|
|
Trade accounts and notes receivable |
(25,265) |
(33,408) |
(59,643) |
(86,766) |
Inventories |
(23,000) |
(53,185) |
(203,335) |
(168,372) |
Accounts payable and accrued liabilities |
(78,788) |
16,000 |
4,519 |
53,577 |
Income taxes payable, refundable income taxes and noncurrent taxes payable |
37,388 |
31,983 |
21,751 |
(3,292) |
Other |
(12,460) |
(5,076) |
(1,659) |
8,122 |
Net cash provided by operating activities |
32,053 |
115,980 |
352,283 |
400,454 |
Investing activities: |
|
|
|
|
Acquisition of property and equipment |
(147,356) |
(76,640) |
(466,192) |
(210,626) |
Acquisition of business, net of cash acquired |
— |
(89,692) |
(4,474,925) |
(91,942) |
Other |
(5,716) |
34 |
(4,592) |
4,450 |
Net cash used in investing activities |
(153,072) |
(166,298) |
(4,945,709) |
(298,118) |
Financing activities: |
|
|
|
|
Proceeds from revolving credit facility, short-term debt and long-term debt |
— |
50,000 |
5,416,753 |
501,000 |
Payments of revolving credit facility, short-term debt and long-term debt |
(70,000) |
(50,000) |
(486,000) |
(651,000) |
Payments for debt issuance costs |
1 |
— |
(99,488) |
(5,069) |
Payments for dividends |
(14,896) |
(10,895) |
(57,309) |
(43,545) |
Issuance of common stock |
5,404 |
6,872 |
16,168 |
24,744 |
Taxes paid related to net share settlement of equity awards |
(73) |
(722) |
(22,820) |
(16,090) |
Repurchase and retirement of common stock |
— |
(17,109) |
— |
(67,109) |
Other |
(242) |
(130) |
(1,101) |
(19,428) |
Net cash (used in) provided by financing activities |
(79,806) |
(21,984) |
4,766,203 |
(276,497) |
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
9,597 |
(885) |
(11,903) |
(4,167) |
(Decrease) increase in cash, cash equivalents and restricted cash |
(191,228) |
(73,187) |
160,874 |
(178,328) |
Cash, cash equivalents and restricted cash at beginning of period |
754,667 |
475,752 |
402,565 |
580,893 |
Cash, cash equivalents and restricted cash at end of period |
|
|
|
|
Segment Information (In thousands) (Unaudited) |
||||||
|
Three months ended |
|
Twelve months ended |
|||
Net sales |
|
|
|
|
|
|
Specialty Chemicals and Engineered Materials |
|
|
|
|
|
|
Microcontamination Control |
284,676 |
258,866 |
280,550 |
|
1,105,996 |
919,363 |
Advanced Materials Handling |
213,890 |
197,703 |
210,405 |
|
846,492 |
704,946 |
Advanced Planarization Solutions |
253,798 |
23,041 |
293,854 |
|
606,614 |
85,621 |
Inter-segment elimination |
(10,508) |
(9,369) |
(15,173) |
|
(50,663) |
(36,707) |
Total net sales |
|
|
|
|
|
|
|
Three months ended |
|
Twelve months ended |
|||
Segment profit |
|
|
|
|
|
|
Specialty Chemicals and Engineered Materials |
|
|
|
|
|
|
Microcontamination Control |
107,413 |
94,203 |
105,335 |
|
411,475 |
321,300 |
Advanced Materials Handling |
48,045 |
45,304 |
42,077 |
|
183,738 |
159,995 |
Advanced Planarization Solutions |
56,661 |
8,583 |
18,903 |
|
96,902 |
30,415 |
Total segment profit |
226,947 |
186,722 |
200,543 |
|
814,402 |
649,102 |
Amortization of intangibles |
53,462 |
12,240 |
65,346 |
|
143,953 |
47,856 |
Unallocated expenses |
29,709 |
14,938 |
120,308 |
|
190,468 |
49,478 |
Total operating income |
|
|
|
|
|
|
Reconciliation of GAAP Gross Profit to Adjusted Gross Profit (In thousands) (Unaudited) |
||||||
|
Three months ended |
|
Twelve months ended |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit-GAAP |
|
|
|
|
|
|
Adjustments to gross profit: |
|
|
|
|
|
|
Charge for fair value mark-up of acquired inventory sold |
— |
428 |
61,932 |
|
61,932 |
428 |
Adjusted gross profit |
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin - as a % of net sales |
42.8 % |
46.5 % |
37.4 % |
|
42.5 % |
46.1 % |
Adjusted gross margin - as a % of net sales |
42.8 % |
46.5 % |
43.6 % |
|
44.4 % |
46.1 % |
Reconciliation of GAAP Segment Profit to Adjusted Operating Income (In thousands) (Unaudited) |
||||||
|
Three months ended |
|
Twelve months ended |
|||
Adjusted segment profit |
|
|
|
|
|
|
SCEM segment profit |
|
|
|
|
|
|
Severance and restructuring costs |
— |
— |
— |
|
— |
167 |
Charge for fair value write-up of acquired inventory sold |
— |
428 |
5,104 |
|
5,104 |
428 |
SCEM adjusted segment profit |
|
|
|
|
|
|
|
|
|
|
|
|
|
MC segment profit |
|
|
|
|
|
|
Severance and restructuring costs |
— |
— |
— |
|
— |
181 |
MC adjusted segment profit |
|
|
|
|
|
|
|
|
|
|
|
|
|
AMH segment profit |
|
|
|
|
|
|
Severance and restructuring costs |
— |
— |
— |
|
— |
127 |
AMH adjusted segment profit |
|
|
|
|
|
|
|
|
|
|
|
|
|
APS segment profit |
|
|
|
|
|
30,415 |
APS Charge for fair value write-up of acquired inventory sold |
— |
— |
56,828 |
|
56,828 |
— |
APS Gain on sale |
(254) |
— |
— |
|
(254) |
— |
APS adjusted segment profit |
|
|
|
|
|
|
|
|
|
|
|
|
|
Unallocated general and administrative expenses |
|
|
|
|
|
|
Unallocated deal and integration costs |
(22,369) |
(4,558) |
(111,040) |
|
(152,238) |
(8,524) |
Unallocated severance and restructuring costs |
— |
— |
— |
|
— |
(54) |
Adjusted unallocated general and administrative expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total adjusted segment profit |
|
|
|
|
|
|
Adjusted unallocated general and administrative expenses |
(7,340) |
(10,380) |
(9,268) |
|
(38,230) |
(40,900) |
Total adjusted operating income |
|
|
|
|
|
|
Reconciliation of GAAP Net Income to Adjusted Operating Income and Adjusted EBITDA (In thousands) (Unaudited) |
||||||
|
Three months ended |
|
Twelve months ended |
|||
|
|
|
|
|
|
|
Net sales |
|
|
|
|
|
|
Net income (loss) |
|
|
|
|
|
|
Net income (loss) - as a % of net sales |
6.1% |
18.6% |
(7.4%) |
|
6.4% |
17.8% |
Adjustments to net income (loss): |
|
|
|
|
|
|
Income tax expense (benefit) |
7,783 |
30,003 |
(7,015) |
|
38,160 |
69,950 |
Interest expense, net |
82,013 |
9,434 |
82,755 |
|
208,975 |
40,997 |
Other expense, net |
(3,447) |
1,888 |
12,852 |
|
23,926 |
31,695 |
GAAP - Operating income |
143,776 |
159,544 |
14,889 |
|
479,981 |
551,768 |
Operating margin - as a % of net sales |
15.2% |
25.1% |
1.5% |
|
14.6% |
24.0% |
Charge for fair value write-up of acquired inventory sold |
— |
428 |
61,932 |
|
61,932 |
428 |
Deal and transaction costs |
258 |
4,744 |
31,867 |
|
39,543 |
4,744 |
Integration costs |
18,558 |
(186) |
20,762 |
|
50,731 |
3,780 |
Contractual and non-cash integration costs |
3,553 |
— |
58,411 |
|
61,964 |
— |
Severance and restructuring costs |
— |
— |
— |
|
— |
529 |
Gain on sale of subsidiary |
(254) |
— |
|
|
(254) |
— |
Amortization of intangible assets |
53,462 |
12,240 |
65,346 |
|
143,953 |
47,856 |
Adjusted operating income |
219,353 |
176,770 |
253,207 |
|
837,850 |
609,105 |
Adjusted operating margin - as a % of net sales |
23.2% |
27.8% |
25.5% |
|
25.5% |
26.5% |
Depreciation |
41,882 |
22,801 |
45,203 |
|
135,371 |
90,311 |
Adjusted EBITDA |
|
|
|
|
|
|
Adjusted EBITDA - as a % of net sales |
27.6% |
31.4% |
30.0% |
|
29.7% |
30.4% |
Reconciliation of GAAP Net Income and Diluted Earnings per Common Share to Non-GAAP Net Income and Diluted Non-GAAP Earnings per Common Share (In thousands, except per share data) (Unaudited) |
||||||
|
Three months ended |
|
Twelve months ended |
|||
|
|
|
|
|
|
|
GAAP net income (loss) |
|
|
(73,703) |
|
|
|
Adjustments to net income: |
|
|
|
|
|
|
Charge for fair value write-up of inventory acquired |
— |
428 |
61,932 |
|
61,932 |
428 |
Deal and transaction costs |
258 |
4,744 |
31,867 |
|
39,543 |
4,744 |
Integration costs |
18,558 |
(186) |
20,762 |
|
50,731 |
3,780 |
Contractual and non-cash integration costs |
3,553 |
— |
58,411 |
|
61,964 |
— |
Severance and restructuring costs |
— |
— |
— |
|
— |
529 |
Loss on extinguishment of debt and modification |
1,052 |
— |
2,235 |
|
3,287 |
23,338 |
Gain on Sale |
(254) |
— |
— |
|
(254) |
— |
Interest expense, net |
— |
— |
2,397 |
|
29,822 |
— |
Amortization of intangible assets |
53,462 |
12,240 |
65,346 |
|
143,953 |
47,856 |
Tax effect of adjustments to net income and discrete items1 |
(9,605) |
(3,662) |
(41,477) |
|
(65,728) |
(20,411) |
Non-GAAP net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) per common share |
|
|
|
|
|
|
Effect of adjustments to net income (loss) |
|
|
|
|
|
|
Diluted non-GAAP earnings per common share |
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted weighted averages shares outstanding |
149,909 |
136,629 |
148,570 |
|
143,146 |
136,574 |
Effect of adjustment to diluted weighted average shares outstanding |
— |
— |
1,099 |
|
— |
— |
Diluted non-GAAP weighted average shares outstanding |
149,909 |
136,629 |
149,669 |
|
143,146 |
136,574 |
1The tax effect of pre-tax adjustments to net income was calculated using the applicable marginal tax rate during the respective years. |
Reconciliation of GAAP Outlook to Non-GAAP Outlook (In millions, except per share data) (Unaudited) |
|
|
First -Quarter Outlook |
Reconciliation GAAP Operating Margin to non-GAAP Operating Margin and Adjusted EBITDA Margin |
|
Net sales |
|
GAAP - Operating income |
|
Operating margin - as a % of net sales |
10% - 12% |
Deal, transaction and integration costs |
20 |
Amortization of intangible assets |
65 |
Adjusted operating income |
|
Adjusted operating margin - as a % of net sales |
20% - 21% |
Depreciation |
40 |
Adjusted EBITDA |
|
Adjusted EBITDA - as a % of net sales |
25% - 26% |
|
First -Quarter Outlook |
Reconciliation GAAP net income to non-GAAP net income |
|
GAAP net income |
|
Adjustments to net income: |
|
Deal, transaction and integration costs |
20 |
Amortization of intangible assets |
65 |
Income tax effect |
(18) |
Non-GAAP net income |
|
|
First -Quarter Outlook |
Reconciliation GAAP diluted earnings per share to non-GAAP diluted earnings per share |
|
Diluted earnings per common share |
|
Adjustments to diluted earnings per common share: |
|
Deal, transaction and integration costs |
0.14 |
Amortization of intangible assets |
0.43 |
Income tax effect |
(0.12) |
Diluted non-GAAP earnings per common share |
|
Reconciliation of Proforma GAAP (In thousands) (Unaudited) |
||||||||
|
Three months ended |
|
Twelve months ended |
|
|
|
||
|
|
|
|
|
|
|
4Q22 over 4Q21 |
YTD 4Q22 over 4Q21 |
Proforma GAAP |
|
|
|
|
|
|
(0.4) % |
11.4 % |
Less: Wood treatment |
— |
14,958 |
|
11,107 |
70,823 |
|
|
|
Proforma Net Sales - Non GAAP |
|
|
|
|
|
|
1.2 % |
13.4 % |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230214005217/en/
VP of Investor Relations
T + 1 952 556 1844
bill.seymour@entegris.com
Source: